Ignite Creation Date:
2025-12-24 @ 12:49 PM
Ignite Modification Date:
2025-12-29 @ 8:25 AM
Study NCT ID:
NCT07168161
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2025-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Sponsor:
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-29
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-04
First Submit QC Date:
None
Study First Post Date:
2025-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED